168 related articles for article (PubMed ID: 35135919)
21. Diagnosis and management of pancreatic neuroendocrine tumor in von Hippel-Lindau disease.
Tamura K; Nishimori I; Ito T; Yamasaki I; Igarashi H; Shuin T
World J Gastroenterol; 2010 Sep; 16(36):4515-8. PubMed ID: 20857520
[TBL] [Abstract][Full Text] [Related]
22. Use of sunitinib in a 30-year-old woman with pancreatic neuroendocrine tumors associated with Von Hippel-Lindau syndrome.
Wang W; Jiang CY; Wang HW
J Clin Gastroenterol; 2015 Jan; 49(1):89-90. PubMed ID: 24921213
[No Abstract] [Full Text] [Related]
23. Pancreatic mixed serous neuroendocrine neoplasm with clear cells leading to diagnosis of von Hippel Lindau disease.
Kakkar A; Sharma MC; Yadav R; Panwar R; Mathur SR; Iyer VK; Sahni P
Pathol Res Pract; 2016 Aug; 212(8):747-50. PubMed ID: 27161305
[TBL] [Abstract][Full Text] [Related]
24. Pancreatic involvement in von Hippel-Lindau disease. The Groupe Francophone d'Etude de la Maladie de von Hippel-Lindau.
Hammel PR; Vilgrain V; Terris B; Penfornis A; Sauvanet A; Correas JM; Chauveau D; Balian A; Beigelman C; O'Toole D; Bernades P; Ruszniewski P; Richard S
Gastroenterology; 2000 Oct; 119(4):1087-95. PubMed ID: 11040195
[TBL] [Abstract][Full Text] [Related]
25. Distinct DNA Methylation Signatures in Neuroendocrine Tumors Specific for Primary Site and Inherited Predisposition.
Tirosh A; Killian JK; Petersen D; Zhu YJ; Walker RL; Blau JE; Nilubol N; Patel D; Agarwal SK; Weinstein LS; Meltzer P; Kebebew E
J Clin Endocrinol Metab; 2020 Oct; 105(10):3285-94. PubMed ID: 32706863
[TBL] [Abstract][Full Text] [Related]
26. Long-term Prognosis of Resected Pancreatic Neuroendocrine Tumors in von Hippel-Lindau Disease Is Favorable and Not Influenced by Small Tumors Left in Place.
de Mestier L; Gaujoux S; Cros J; Hentic O; Vullierme MP; Couvelard A; Cadiot G; Sauvanet A; Ruszniewski P; Richard S; Hammel P
Ann Surg; 2015 Aug; 262(2):384-8. PubMed ID: 25185468
[TBL] [Abstract][Full Text] [Related]
27. [Pancreatic tumor: unusual onset of Von-Hippel Lindau syndrome].
Garberini A; Caricato M; Valeri S; Alloni R; Ausania F; Rosignoli A; Greco S; Rabitti C; Coppola R
Suppl Tumori; 2005; 4(3):S56. PubMed ID: 16437901
[TBL] [Abstract][Full Text] [Related]
28. [Inherited tumor syndromes of gastroenteropancreatic and thoracic neuroendocrine neoplasms].
Couvelard A; Scoazec JY
Ann Pathol; 2020 Apr; 40(2):120-133. PubMed ID: 32035641
[TBL] [Abstract][Full Text] [Related]
29. Clinical presentation, genotype-phenotype correlations, and outcome of pancreatic neuroendocrine tumors in Von Hippel-Lindau syndrome.
Penitenti F; Landoni L; Scardoni M; Piredda ML; Cingarlini S; Scarpa A; D'Onofrio M; Girelli D; Davi MV
Endocrine; 2021 Oct; 74(1):180-187. PubMed ID: 34036514
[TBL] [Abstract][Full Text] [Related]
30. Long-term high-dose proton pump inhibitor administration to Helicobacter pylori-infected Mongolian gerbils enhances neuroendocrine tumor development in the glandular stomach.
Tsukamoto H; Mizoshita T; Sasaki M; Mizushima T; Tanida S; Ozeki K; Hirata Y; Shimura T; Kataoka H; Kamiya T; Nojiri S; Tsukamoto T; Tatematsu M; Joh T
Asian Pac J Cancer Prev; 2011; 12(4):1049-54. PubMed ID: 21790250
[TBL] [Abstract][Full Text] [Related]
31. Neuroendocrine neoplasms in the context of inherited tumor syndromes: a reappraisal focused on targeted therapies.
Ruggeri RM; Benevento E; De Cicco F; Fazzalari B; Guadagno E; Hasballa I; Tarsitano MG; Isidori AM; Colao A; Faggiano A;
J Endocrinol Invest; 2023 Feb; 46(2):213-234. PubMed ID: 36038743
[TBL] [Abstract][Full Text] [Related]
32. A gastric neuroendocrine tumor after prolonged use of proton pump inhibitors.
Prado PHT; Paula RV; de Faria ATR; Silva BL; Ardengh JC
Rev Esp Enferm Dig; 2023 Apr; 115(4):209-210. PubMed ID: 36148661
[TBL] [Abstract][Full Text] [Related]
33. An Advanced Well-differentiated Pancreatic Neuroendocrine Carcinoma (NET-G3) Associated with Von Hippel-Lindau Disease.
Miki M; Kawabe K; Igarashi H; Abe T; Ohishi Y; Hashimoto R; Karashima T; Yamasaki I; Inoue K; Ito T; Ogawa Y
Intern Med; 2018 Jul; 57(14):2007-2011. PubMed ID: 29491307
[TBL] [Abstract][Full Text] [Related]
34. Netazepide, a gastrin receptor antagonist, normalises tumour biomarkers and causes regression of type 1 gastric neuroendocrine tumours in a nonrandomised trial of patients with chronic atrophic gastritis.
Moore AR; Boyce M; Steele IA; Campbell F; Varro A; Pritchard DM
PLoS One; 2013; 8(10):e76462. PubMed ID: 24098507
[TBL] [Abstract][Full Text] [Related]
35. Endocrine manifestations of von Hippel-Lindau disease.
Cassol C; Mete O
Arch Pathol Lab Med; 2015 Feb; 139(2):263-8. PubMed ID: 25611110
[TBL] [Abstract][Full Text] [Related]
36. Pancreatic neuroendocrine tumors in von Hippel-Lindau disease.
de Mestier L; Hammel P
Scand J Gastroenterol; 2015 Aug; 50(8):1054-5. PubMed ID: 25731071
[No Abstract] [Full Text] [Related]
37. Safety of proton pump inhibitors and risk of gastric cancers: review of literature and pathophysiological mechanisms.
Ko Y; Tang J; Sanagapalli S; Kim BS; Leong RW
Expert Opin Drug Saf; 2016 Jan; 15(1):53-63. PubMed ID: 26560097
[TBL] [Abstract][Full Text] [Related]
38. [Genetic analysis of a family with Von Hippel-Lindau syndrome].
Lafuente-Sanchis A; Cuevas JM; Alemany P; Cremades A; Zúñiga Á
Rev Esp Patol; 2017; 50(1):64-67. PubMed ID: 29179968
[TBL] [Abstract][Full Text] [Related]
39. Laparoscopic organ-sparing resection of von Hippel-Lindau disease-associated pancreatic neuroendocrine tumors.
von Dücker L; Walz MK; Voss C; Arnold G; Eng C; Neumann HP
World J Surg; 2011 Mar; 35(3):563-7. PubMed ID: 21181474
[TBL] [Abstract][Full Text] [Related]
40. Renal Cell Carcinoma and a Pancreatic Neuroendocrine Tumor: A Coincidence or Instance of Von Hippel-Lindau Disease?
Matsubayashi H; Niwakawa M; Uesaka K; Sasaki K; Kiyozumi Y; Ishiwatari H; Hotta K; Imai K; Ito S; Takizawa K; Tanaka M; Kawata N; Kakushima N; Ono H
Intern Med; 2017 Sep; 56(17):2281-2284. PubMed ID: 28794363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
